Health2Tech
Phase Capital founder Kavya Sharman explains the difference between techbio and biotech and where GenAI is already changing lab work. We discuss autonomous labs, realistic disease “cure” timelines, and her thesis as an investor.
73 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Health2Tech-Community!